dm+d

346671007

Articles

Summary of NICE guidance for Tuberculosis

13 November 2020Since this edition of NICE Bites was published, the MHRA has issued restrictions and precautions on the use of fluoroquinolone antibiotics because of rare reports…

RMOC Recommendation: Standardising strengths of high risk, unlicensed oral liquids formulations for anti-TB medicines

9 April 2018At the meeting on 26th October 2017 the Regional Medicines Optimisation Committee (North) endorsed the approach put forward by the NHS Pharmaceutical Quality Assurance Committee…
Search Articles

Medicine Compliance Aid Stability

RifaterSanofi

Sanofi
Rifater
Tablets 120mg/50mg/300mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Rifater should be protected from excessive humidity and stored at 15–30°C
31 July 2015